|
|
N = 41 |
% |
Age at diagnosis |
Median age |
58 |
|
Range |
35-77 |
|
Sex |
Male |
29 |
71 |
Female |
12 |
29 |
ISS |
I |
16 |
39 |
II |
12 |
29 |
III |
13 |
32 |
Immunoglobulin isotype |
IgG |
24 |
59 |
IgA |
5 |
12 |
IgM |
3 |
7 |
LC |
9 |
22 |
Karyotype |
Normal |
8 |
20 |
Aberrant |
28 |
68 |
Not reported |
5 |
12 |
Cytogenetic risk group (by FISH) |
High risk* |
9 |
22 |
Standard risk |
27 |
66 |
|
N: Number of Patients; ISS: International Staging System; LC: Light chain
myeloma; FISH: Fluorescence In-Situ Hybridization. *High risk cytogenetics
defined as t(4;14), t(14;16) and/or del17p |
Table 1: Clinical data and disease characteristics of the patients. |